Table 3

 Distribution of 598 baseline study participants by strength of evidence for workplace exacerbation of asthma

Exposure score†work related symptom scoreTotal
0123
*23% (n = 136) of the 598 study participants had moderate or strong evidence, and were classified as having workplace exacerbation of asthma.
†Based on the higher of two scores for sensitiser and irritant agents, as independently assigned by two researchers after review of each participant’s work history for the 12 months before interview.
‡Includes 41 participants who were unemployed during the 12 months before interview.
0215‡921513335
NoneWeakWeakModerate*
1121662211220
WeakModerate*Moderate*Strong*
219193243
WeakModerate*Strong*Strong*
Total3551774026598